Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina
- PMID: 9314871
- DOI: 10.1016/S0140-6736(97)04240-2
Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina
Abstract
Background: Factors that influence shedding of HIV-1 infected cells in cervical and vaginal secretions may be important determinants of sexual and vertical transmission of the virus. We investigated whether hormonal contraceptive use, vitamin A deficiency, and other variables were risk factors for cervical and vaginal shedding of HIV-infected cells.
Methods: Between December, 1994, and April, 1996, women who attended a municipal sexually transmitted diseases (STDs) clinic in Mombasa, Kenya, and had previously tested positive for HIV-1, were invited to take part in our cross-sectional study. Cervical and vaginal secretions from 318 women were evaluated for the presence of HIV-1 infected cells by PCR amplification of gag DNA sequences.
Findings: HIV-1 infected cells were detected in 51% of endocervical and 14% of vaginal-swab specimens. Both cervical and vaginal shedding of HIV-1 infected cells were highly associated with CD4 lymphocyte depletion (p = 0.00001 and p = 0.003, respectively). After adjustment for CD4 count, cervical proviral shedding was significantly associated with use of depot medroxyprogesterone acetate (odds ratio 2.9, 95% CI 1.5-5.7), and with use of low-dose and high-dose oral contraceptive pills (3.8, 1.4-9.9 and 12.3, 1.5-101, respectively). Vitamin A deficiency was highly predictive of vaginal HIV-1 DNA shedding. After adjustment for CD4 count, severe vitamin A deficiency, moderate deficiency, and low normal vitamin A status were associated with 12.9, 8.0, and 4.9-fold increased odds of vaginal shedding, respectively. Gonococcal cervicitis (3.1, 1.1-9.8) and vaginal candidiasis (2.6, 1.2-5.4) were also correlated with significant increases in HIV-1 DNA detection, but Chlamydia trachomatis and Trichomonas vaginalis were not.
Interpretation: Our study documents several novel correlates of HIV-1 shedding in cervical and vaginal secretions, most notably hormonal contraceptive use and vitamin A deficiency. These factors may be important determinants of sexual or vertical transmission of HIV-1 and are of public health importance because they are easily modified by simple interventions.
PIP: Correlates of HIV-1 shedding in cervical and vaginal secretions were investigated in a cross-sectional study of 318 women previously diagnosed with HIV who presented to a sexually transmitted disease clinic in Mombasa, Kenya, during 1994-96. HIV-infected cells were detected in 51% of endocervical and 14% of vaginal swab specimens. Both cervical and vaginal shedding of HIV-1 infected cells were highly associated with CD4 lymphocyte depletion. After adjustment for CD4 count, cervical proviral shedding was significantly associated with use of depo medroxyprogesterone acetate (odds ratio [OR], 2.9; 95% confidence interval [CI], 1.5-5.7) and of low- and high-dose oral contraceptives (OR, 3.8; 95% CI, 1.4-9.9 and OR, 12.3; 95% CI, 1.5-101, respectively). After adjustment for CD4 count, severe vitamin A deficiency, moderate deficiency, and low-normal vitamin A status were associated with 12.9, 8.0, and 4.9-fold increased odds of vaginal shedding, respectively. Finally, gonococcal cervicitis (OR, 3.1; 95% CI, 1.1-9.8) and vaginal candidiasis (OR, 2.6; 95% CI, 1.2-5.4), but not Chlamydia trachomatis and Trichomonas vaginalis, were correlated with significant increases in HIV-1 DNA detection. These risk factors, easily modifiable by simple interventions, may be important determinants of sexual or vertical HIV transmission.
Comment in
-
Hormonal contraception and genital-tract shedding of HIV-1-infected cells.Lancet. 1998 Jan 24;351(9098):294-5. doi: 10.1016/s0140-6736(05)78234-9. Lancet. 1998. PMID: 9457127 No abstract available.
Similar articles
-
Selenium deficiency is associated with shedding of HIV-1--infected cells in the female genital tract.J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):360-4. doi: 10.1097/00126334-200104010-00013. J Acquir Immune Defic Syndr. 2001. PMID: 11317079
-
Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency.J Infect Dis. 2000 Jan;181(1):58-63. doi: 10.1086/315188. J Infect Dis. 2000. PMID: 10608751
-
Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya.JAMA. 1993 Jun 9;269(22):2860-4. JAMA. 1993. PMID: 8497089
-
Contraceptive methods and the transmission of HIV: implications for family planning.Genitourin Med. 1994 Apr;70(2):110-7. doi: 10.1136/sti.70.2.110. Genitourin Med. 1994. PMID: 8206468 Free PMC article. Review.
-
Contraception and the prevention of sexually transmitted diseases.Br Med Bull. 1993 Jan;49(1):171-81. doi: 10.1093/oxfordjournals.bmb.a072596. Br Med Bull. 1993. PMID: 8324607 Review.
Cited by
-
Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa.Bull World Health Organ. 2012 Oct 1;90(10):748-55. doi: 10.2471/BLT.12.105700. Epub 2012 Jul 16. Bull World Health Organ. 2012. PMID: 23109742 Free PMC article.
-
Medroxyprogesterone acetate alters Mycobacterium bovis BCG-induced cytokine production in peripheral blood mononuclear cells of contraceptive users.PLoS One. 2011;6(9):e24639. doi: 10.1371/journal.pone.0024639. Epub 2011 Sep 8. PLoS One. 2011. PMID: 21931790 Free PMC article.
-
HIV transmission by HIV-infected women using hormonal contraception.Clin Infect Dis. 2009 Feb 15;48(4):499-500. doi: 10.1086/596551. Clin Infect Dis. 2009. PMID: 19586383 Free PMC article. No abstract available.
-
Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV.Drug Saf. 2016 Nov;39(11):1053-1072. doi: 10.1007/s40264-016-0452-7. Drug Saf. 2016. PMID: 27562873 Free PMC article. Review.
-
Efforts to control sexually transmitted infections as a means to limit HIV transmission: what is the evidence?Curr HIV/AIDS Rep. 2004 Dec;1(4):166-71. doi: 10.1007/s11904-004-0026-7. Curr HIV/AIDS Rep. 2004. PMID: 16091238 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous